PL355453A1 - Pharmaceutical agent - Google Patents

Pharmaceutical agent

Info

Publication number
PL355453A1
PL355453A1 PL02355453A PL35545302A PL355453A1 PL 355453 A1 PL355453 A1 PL 355453A1 PL 02355453 A PL02355453 A PL 02355453A PL 35545302 A PL35545302 A PL 35545302A PL 355453 A1 PL355453 A1 PL 355453A1
Authority
PL
Poland
Prior art keywords
pharmaceutical agent
pharmaceutical
agent
Prior art date
Application number
PL02355453A
Other languages
Polish (pl)
Other versions
PL191525B1 (en
Inventor
Włodzimierz Grabowicz
Original Assignee
Włodzimierz Grabowicz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Włodzimierz Grabowicz filed Critical Włodzimierz Grabowicz
Priority to PL355453A priority Critical patent/PL191525B1/en
Priority to PCT/PL2002/000076 priority patent/WO2004014396A1/en
Publication of PL355453A1 publication Critical patent/PL355453A1/en
Publication of PL191525B1 publication Critical patent/PL191525B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
PL355453A 2002-08-12 2002-08-12 Pharmaceutical agent PL191525B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL355453A PL191525B1 (en) 2002-08-12 2002-08-12 Pharmaceutical agent
PCT/PL2002/000076 WO2004014396A1 (en) 2002-08-12 2002-10-24 Medicament comprising fluocinolone and dexamethasone and/or hydrocortisone and gentamicin and/or neomycin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL355453A PL191525B1 (en) 2002-08-12 2002-08-12 Pharmaceutical agent

Publications (2)

Publication Number Publication Date
PL355453A1 true PL355453A1 (en) 2004-02-23
PL191525B1 PL191525B1 (en) 2006-06-30

Family

ID=31713223

Family Applications (1)

Application Number Title Priority Date Filing Date
PL355453A PL191525B1 (en) 2002-08-12 2002-08-12 Pharmaceutical agent

Country Status (2)

Country Link
PL (1) PL191525B1 (en)
WO (1) WO2004014396A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITBA20110004A1 (en) * 2011-02-07 2012-08-08 Francesco Decenvirale "OINTMENT FOR THE TREATMENT OF SKIN INFLAMMATORY STATES AND ITS PROCESS OF MANUFACTURING"
CN103450295A (en) * 2013-08-28 2013-12-18 南阳普康药业有限公司 Method for purifying gentamicin sulphate
CN105169462B (en) * 2015-10-22 2017-10-17 江苏科技大学 Improve the mixed method of neomycinsulphate dispersing uniformity in vaseline
US20200397720A1 (en) * 2019-06-23 2020-12-24 Charles Huntington Gallina Method and formulation for treatment of wounds by new tissue regeneration with reduced trauma and scar tissue formation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1010363A (en) * 1973-08-09 1977-05-17 Albert M. Kligman Topical composition comprising a corticosteroid and vitamin a acid
YU46838B (en) * 1986-02-14 1994-06-24 Pero Dr. Višnjić PROCEDURE FOR OBTAINING PREPARATIONS FOR THE TREATMENT OF PSORIASIS SKIN DISEASE

Also Published As

Publication number Publication date
WO2004014396A9 (en) 2004-04-08
PL191525B1 (en) 2006-06-30
WO2004014396A1 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
GB0218625D0 (en) Pharmaceutical compounds
GB0210397D0 (en) Pharmaceutical formulations
AU2003291103A8 (en) Pharmaceutical composition
IL164547A0 (en) Pharmaceutical composition
AU2003250372A8 (en) Pharmaceutical composition
GB0215775D0 (en) Pharmaceutical compounds
HUP0303948A2 (en) Solid orally-dispersible pharmaceutical formulation
GB2392093B (en) Pharmaceutical formulations
GB0206505D0 (en) Pharmaceutical combination
PL397022A1 (en) Therapeutic agent
HK1065477A1 (en) Pharmaceutical composition
PL373409A1 (en) Pharmaceutical combination
GB0201520D0 (en) Pharmaceutical uses
GB0316889D0 (en) Pharmaceutical agents
PL355453A1 (en) Pharmaceutical agent
GB0204392D0 (en) Pharmaceutical compound
AU2003238900A8 (en) Pharmaceutical formulation
GB0217703D0 (en) Pharmaceutical composition
GB0224680D0 (en) Pharmaceutical
GB0220451D0 (en) Pharmaceutical use
GB0210240D0 (en) Pharmaceutical combination
GB0225041D0 (en) Pharmaceutical formulation
GB0214491D0 (en) Pharmaceutical composition
GB0213305D0 (en) Pharmaceutical composition
GB0227342D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20090812